![image of ivermectin](https://www.uc.edu/news/articles/2023/05/n21175024/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1685367970510.jpg)
Newsweek: Conservative justices deal a blow to Ivermectin in Wisconsin court battle
UC Law professor weighs in on use of controversial drug used by some to treat COVID-19
The Wisconsin Supreme Court ruled earlier this month that hospitals can’t be forced to issue Ivermectin to patients. It backed an earlier appeals court decision. It stems from a case filed by Allen Gahl, on behalf of his uncle John Zingsheim, against Aurora Health Care in Oct. 2021.
There was a claim that Zingsheim was not provided with Ivermectin by hospital staff after it was requested. Zingsheim later recovered from COVID and was released. An appeals court ruling found healthcare providers were not required to administer treatments desired by patients and found courts had no authority to compel them to do so.
Jennifer Bard, PhD, professor in the University of Cincinnati College of Law, spoke with Newsweek via email about the case.. She said that forcing doctors to administer care “would be dangerous to the public.”
"Many states have already passed laws making it easier for patients to get Ivermectin by protecting doctors who prescribe it from being punished by the state medical court," Bard told Newsweek. "But so far, no state has identified a patient's right to force a doctor or hospital to administer a specific treatment.
"I think this was the right decision because it is consistent with a legal structure that protects patients by holding doctors responsible for providing a nationally recognized standard of care,” according to Bard.
Bard also has a faculty appointment in the Department of Internal Medicine in the UC College of Medicine.
Ivermectin tablets are approved by the FDA to treat people with intestinal strongyloidiasis and onchocerciasis, two conditions caused by parasitic worms. In addition, some topical forms of ivermectin are approved to treat external parasites like head lice and for skin conditions such as rosacea.
The drug gained popularity during the COVID-19 pandemic as an alternative cheap medication promoted by some politicians, physicians and individuals opposed to vaccination. The United States Food and Drug Administration has not authorized or approved ivermectin for the treatment or prevention of COVID-19 in people or animals. Ivermectin has not been shown to be safe or effective for these indications.
Read the full Newsweek article online.
Learn more about Jennifer Bard, PhD, online.
Featured top image: Ivermectin image courtesy of Istock.
Related Stories
Newsweek: Conservative justices deal a blow to Ivermectin in Wisconsin court battle
May 29, 2023
The Wisconsin Supreme Court ruled earlier this month that hospitals can’t be forced to issue Ivermectin to patients. It backed an earlier appeals court decision. Jennifer Bard, PhD, professor at the University of Cincinnati College of Law, weighed in on the decision during an interview with Newsweek.
WLWT: COVID-19 vaccine distribution in Ohio
January 11, 2021
COVID-19 vaccine providers across Ohio will soon get better guidance about the next steps for getting shots into arms. Brett Kissela, MD, spoke to WLWT-TV, Channel 5 and said the benefits of the vaccine outweigh any potential side effects.
US News & World Report: Lung cancer screening and COVID-19
December 21, 2020
New UC research shows a dangerous trend in lung cancer caused by the pandemic.
Drugs.com: Pandemic disrupting lung cancer screening
January 5, 2021
Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.
'I'm a believer': UC dean for research takes next step in COVID-19 trial
January 8, 2021
Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health, learned he received the placebo in the Moderna vaccine clinical trial. He then received the real vaccine to show that he believes in the science.
Cincinnati.com: Lung imaging to predict neurological issues
March 22, 2021
A UC study reveals a visual correlation between the severity of COVID-19 in the lungs (using CT scans) and the severity of effects on patients' brains (using MRI scans).
WVXU: COVID-19, lung and brain images and stroke risk
March 15, 2021
University of Cincinnati researchers say for the first time they have a visual correlation between the severity of COVID-19 in the lungs and the effect on patients' brains, WVXU-FM reports.
COVID-19 Conversations Podcast: Participation in vaccine trial
December 17, 2020
UC's Brett Kissela, MD, discusses participating in the Moderna vaccine trial on an African Alliance podcast.
Local 12: Pregnancy and addiction
March 8, 2021
Local 12 reports on a new study that could give pregnant women with addiction a new tool to deliver a healthy baby. Christine Wilder, MD, is interviewed.
ABC News: Impact of pandemic cancer screening pause
March 16, 2021
Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.